Celldex Therapeutics shares owned by Metropolitan Life Insurance Company
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Metropolitan Life Insurance Company
from 13F filings
Historical chart of Metropolitan Life Insurance Company investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Metropolitan Life Insurance Company consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Celldex Therapeutics by Metropolitan Life Insurance Company
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $108k | 2.7k | 39.66 |
2023-09-30 | $75k | 2.7k | 27.52 |
2023-06-30 | $86k | 2.5k | 33.93 |
2023-03-31 | $92k | 2.5k | 35.98 |
2022-12-31 | $126k | 2.8k | 44.57 |
2022-09-30 | $84k | 3.0k | 28.11 |
2022-06-30 | $81k | 3.0k | 26.96 |
2022-03-31 | $102k | 3.0k | 34.05 |
2021-12-31 | $469k | 12k | 38.64 |
2021-09-30 | $656k | 12k | 54.00 |
2021-06-30 | $371k | 11k | 33.40 |
More positions owned by Metropolitan Life Insurance Company
View all positions for Metropolitan Life Insurance Company